Titanium MPJ (Toe Implant) TOE JOINT TITANIUM PC MS, Part ID 17197
FDA Device Recall #Z-0690-2022 — Class II — February 1, 2022
Recall Summary
| Recall Number | Z-0690-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 1, 2022 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | BioPro, Inc. |
| Location | Port Huron, MI |
| Product Type | Devices |
Product Description
Titanium MPJ (Toe Implant) TOE JOINT TITANIUM PC MS, Part ID 17197
Reason for Recall
There is an incorrect statement regarding MR Compatibility in the BioPro Titanium MPJ implant IFU (IFU BP102303 rev 05) and patient implant cards (22266 rev 00) which indicates that the BioPro MPJ Implant has been tested for safety and compatibility in the MR Environment and is MR Conditional. MR Testing has not been conducted on the titanium version of the MPJ.
Distribution Pattern
US Nationwide distribution in the states of CT, KY, NM, PA, TN, and SD.
Lot / Code Information
Lot Number: 128361; UDI: 00810012480277
Other Recalls from BioPro, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0152-2026 | Class II | BioPro Endo Head (Ceramic) Product ID/Descri... | Sep 9, 2025 |
| Z-0149-2026 | Class II | BioPro Endo Head (Metal uni-polar, 38-55) Pr... | Sep 9, 2025 |
| Z-0150-2026 | Class II | BioPro Bipolar Head Product ID/Description ... | Sep 9, 2025 |
| Z-0148-2026 | Class II | BioPro Femoral Head (Metal 22, 28, 32, 36, 40) ... | Sep 9, 2025 |
| Z-0151-2026 | Class II | BioPro Femoral Head (Ceramic heads 28-30) Pr... | Sep 9, 2025 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.